Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 101,456 | 114,821 | 167,705 | 166,549 | 213,059 |
| Marketable Securities | N/A | N/A | N/A | N/A | 1,435 |
| Receivables | 201,069 | 171,259 | 210,155 | 210,308 | 204,912 |
| Inventories | 68,167 | 65,128 | 65,021 | 60,373 | 63,680 |
| Other current assets | 41,967 | 68,114 | 55,886 | 42,049 | 39,906 |
| TOTAL | $412,659 | $419,322 | $498,767 | $479,279 | $522,992 |
| Non-Current Assets | |||||
| PPE Net | 428,004 | 387,501 | 386,310 | 349,623 | 360,943 |
| Intangibles | 1,476,530 | 1,272,611 | 1,634,209 | 1,645,579 | 1,664,533 |
| Other Non-Current Assets | 93,231 | 458,775 | 70,109 | 73,526 | 78,548 |
| TOTAL | $1,997,765 | $2,118,887 | $2,090,628 | $2,068,728 | $2,104,024 |
| Total Assets | $2,410,424 | $2,538,209 | $2,589,395 | $2,548,007 | $2,627,016 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 36,403 | 36,263 | 80,555 | 80,868 | 80,868 |
| Accounts payable and accrued liabilities | 34,133 | 28,727 | 25,753 | 24,347 | 26,397 |
| Accrued Expenses | 65,987 | 76,863 | 85,029 | 79,448 | 86,054 |
| Other current liabilities | 31,121 | 43,581 | 29,568 | 27,707 | 23,985 |
| TOTAL | $268,023 | $311,412 | $318,250 | $316,220 | $325,760 |
| Non-Current Liabilities | |||||
| Long Term Debt | 270,652 | 259,902 | 297,728 | 325,677 | 585,772 |
| Deferred Revenues | 100,379 | 95,564 | 97,345 | 103,850 | 108,456 |
| Other Non-Current Liabilities | 134,694 | 139,882 | 187,769 | 174,427 | 197,693 |
| TOTAL | $405,346 | $399,784 | $485,497 | $500,104 | $783,465 |
| Total Liabilities | $673,369 | $711,196 | $803,747 | $816,324 | $1,109,225 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,128 | 71,992 | 72,322 | 71,780 | 66,663 |
| Common Shares | 729 | 724 | 723 | 717 | 666 |
| Retained earnings | -21,209 | 78,906 | 28,488 | -3,585 | -35,445 |
| Other shareholders' equity | 10,610 | -12,242 | -14,720 | -24,005 | -443 |
| TOTAL | $1,737,055 | $1,827,013 | $1,785,648 | $1,731,683 | $1,517,791 |
| Total Liabilities And Equity | $2,410,424 | $2,538,209 | $2,589,395 | $2,548,007 | $2,627,016 |